A third of NHS shakes and soups diet participants achieve diabetes remission

FHS
August 8, 2024
12:51 pm

Researchers assessed insulin-independent diabetes remission by total dietary replacement in England.

Deep learning revolutionizes RNA 3D structure prediction with RhoFold+

Researchers introduce RhoFold+, a groundbreaking deep learning model that predicts RNA 3D structures with unprecedented accuracy and efficiency, addressing critical challenges in structural biology.

November 24, 2024

Pharmalittle: We’re reading about a key Merck drug trial, cheap Wegovy in China, and more

Top of the morning to you, and a fine one it is. Clear blue skies and cool breezes are wafting over the Pharmalot campus, where

November 19, 2024

Alexion adds fourth indication for C5 inhibitor Ultomiris in rare autoimmune disorder

AstraZeneca’s rare disease arm Alexion scored its fourth approval for Ultomiris in a rare autoimmune disorder after Phase 3 data showed there were zero patients with

March 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.